Baum M
1998-2001Select, Recent Publications
Is
clinical breast examination an acceptable alternative to mammographic
screening?. [Review].
Mittra
I, Baum M, Thornton H, Houghton J. BMJ. 2000;321:1071-3. (FULL-TEXT)
Are
randomized trials of hormone replacement therapy in symptomatic
women with breast cancer feasible?
Marsden
J, Whitehead M, A'Hern R, Baum M, Sacks N. Fertility &
Sterility. 2000;73:292-9.
Effect
of screening programme on mortality from breast cancer. Investment
in treatment would be more cost effective.
Baum
M, Tobias JS. BMJ. 2000;321:1528. (FULL-TEXT LETTERS)
Survival
and reduction in mortality from breast cancer. Impact of mammographic
screening is not clear.
Baum
M. BMJ. 2000;321:1470; discussion 1471-2. (FULL-TEXT LETTERS)
Contrast-enhanced
colour Doppler ultrasonography in suspected breast cancer
recurrence.
Winehouse
J, Mdouek, Holz K, et al. British Journal of Surgery. 1999;86:1198-201.
Setting
up a breast cancer family history clinic. [Review].
Saunders
C, Vijay V, Stein J, Baum M. Annals of the Royal College of
Surgeons of England. 1999;81:393-8.
The
effect of anastrozole on the pharmacokinetics of tamoxifen
in post-menopausal women with early breast cancer.
Dowsett
M, Tobias JS, Howell A, et al. British Journal of Cancer.
1999;79:311-5.
Contribution
of randomised controlled trials to understanding and management
of early breast cancer. [Review].
Baum
M, Houghton J. BMJ. 1999;319:568-71. (FULL-TEXT)
Use
of aromatase inhibitors in the adjuvant treatment of breast
cancer. [Review].
Baum
M. Endocrine-Related Cancer. 1999;6:231-4.
Campaign
strategy and tactics for clinical trials in surgical oncology.
[Review].
Rew
DA, Baum M. European Journal of Surgical Oncology. 1998;24:269-74.
Clinical
prognostic and predictive factors for primary chemotherapy
in operable breast cancer.
Ellis
P, Smith I, Ashley S, et al. Journal of Clinical Oncology.
1998;16:107-14.
Putting
the risk of breast cancer in perspective [see comments]. [Review].
Bunker
JP, Houghton J, Baum M. BMJ. 1998;317:1307-9. (FULL-TEXT)
Tamoxifen--the
treatment of choice. Why look for alternatives?
Baum
M. British Journal of Cancer. 78 Suppl 4:1-4, 1998.
|
